Background. Hypokalaemic periodic paralysis (hypoPP) is an autosomal dominant disorder involving the abnormal function of ion channels and it is characterized by paralysis attacks of varying severity, accompanied by a fall in blood potassium levels. Linkage analysis showed that the candidate locus responsible for hypoPP was localized to chromosome 1q31-32, and this locus encoded the muscle dihydropyridine-sensitive calcium channel a 1 -subunit (CACNA1S). So far, three different mutations in CACNA1S gene have been identi®ed in patients with hypoPP: Arg528His, Arg1239His and Arg1239Gly in Caucasian patients. However, there are few reports about the mutations of CACNA1S gene in other races. Methods. In this study, four Korean families with ®ve hypoPP patients were screened for mutations of CACNA1S gene with polymerase chain reaction-based restriction analysis and single-strand conformation polymorphism analysis. To determine the mode of inheritance, haplotype analysis was done with three microsatellite markers (D1S1726, CACNL1A3, and D1S1723). Results. Arg528His mutation was detected in three families, and one family had no known mutations. Moreover, for the ®rst time, we detected de novo Arg528His mutations in two out of three families with hypoPP. Haplotype analysis using three microsatellite markers (D1S1726, CACNL1A3, and D1S1723) suggested the occurrence of de novo Arg528His mutations in two of the three families with Arg528His mutation. Conclusions. Arg528His mutations of CACNA1S, including de novo Arg528His mutations, were found in Korean patients with hypoPP. These results imply that de novo mutation, in addition to non-penetrance, is one of the genetic mechanisms that can explain the previous clinical observation that hypoPP occurs sporadically without family history.
Introduction
Familial hypokalaemic periodic paralysis (hypoPP) is an autosomal dominant disorder of the skeletal muscle characterized by episodic attacks of muscle weakness that are associated with a decrease in blood potassium levels. The attacks occur variously from once in a lifetime to several times per week. The prevalence has been estimated at about 1u100 000 w1x. The onset of hypoPP usually occurs in the second decade of the life, and one-third of the patients develop the disease before the age of 16 years. w2,3x.
Recently, the hypoPP locus was genetically mapped to chromosome 1q31-32, where the a 1 -subunit of the dihydropyridine receptor gene (CACNA1S) is known to reside w4±6x. The dihydropyridine receptor belongs to a family of voltage-gated ion channels and, with potassium, sodium, and calcium channels, shares a common structure consisting of six transmembrane segments w7x. The a 1 -subunit of the dihydropyridine receptor is composed of four domains w8x. Deleterious mutations have been demonstrated in the voltagesensor segment S4 of the dihydropyridine receptor, establishing CACNA1S as the causative gene for hypoPP w5,9x.
So far, three missense mutations have been identi®ed in the highly conserved putative membrane spanning domains (Arg528His, Arg1239His, and Arg1239Gly). Arg528His and Arg1239His presently account for the majority of identi®ed mutations in hypoPP families w5,9±11x. Incomplete penetrance was observed in families displaying the Arg528His mutations w11,12x.
In the present study, we performed mutation analysis regarding the three known mutations of CACNA1S gene in four Korean families with hypoPP. We identi®ed Arg528His mutation in three families, and two of the families showed de novo mutations.
Subjects and methods

Patients
Five hypoPP patients and their family members from four Korean families were analysed. The characteristics and clinical features of the patients are summarized in Table 1 . The patients presented typical clinical features of hypoPP, i.e. episodic paralysis of limbs with concomitant hypokalaemia that improved with normalizing serum potassium concentration. The paralysis attacks always started at dawn. All patients responded to treatment and were free of paralysis attacks after the treatment. Informed consent was obtained from all patients and the project was approved by the institutional review board.
Restriction analysis for mutations
Genomic DNA was prepared from the peripheral blood of ®ve hypoPP patients and their family members, using a method described by John et al. w13x. As the Arg528His mutation disrupts a BbvI restriction site, it was easily analysed by polymerase chain reaction (PCR) according to the previous protocol that used the forward primer 59-GGAGA-TCCTGCTGG TGGAGTCG-39 and reverse primer 59-TC-CTCAGGAGGCGGATGCAG-39 w9,12x. The PCR products were digested overnight with BbvI and electrophoresed on 4% NuSieve 1 3 : 1 agarose gels (FMC Bioproducts, Rockland, ME). This analysis was also performed on 50 unaffected and unrelated Koreans. As the Arg1239His mutation creates a NlaIII restriction site, it was also analysed by PCR using the forward primer 59-CGCATCTCCAGCGCCTTCTTC-39 and reverse primer 59-CGTCCACAGGAGGGTTCGCAC-39 w9,12x. The PCR products were digested with NlaIII, electrophoresed on 20% polyacrylamide gels, and stained with Syber green (Figure 1) .
Sequencing of the mutation was performed on at least one affected individual per family.
Single-strand conformation polymorphism analysis
For internal labelling, 1 mCi of wa-32 PxdCTP (Amersham Pharmacia Biotech, Uppsala, Sweden) was added to the PCR reaction mixture. Three microlitres of radiolabelled PCR products were mixed with the loading buffer. The samples were denatured by boiling for 5 min and then cooled with ice. Samples were loaded on a 0.7 3 MDE TM gel (FMC Bioproducts, Rockland, ME) in 0.6 3 TBE buffer. Electrophoresis was carried out with an IBI sequencing apparatus (Eastman Kodak Co., Rochester, NY) at 8 W for 12 h at room temperature. After electrophoresis, each gel was dried and autoradiographed for 1 day.
Haplotype and genetic analysis
Haplotypes of the four hypoPP families were constructed by using three dinucleotide repeat polymorphisms (D1S1273, D1S1276, and CACNL1A3) w6,14x. For internal labelling, 1 mCi of wa-32 PxdCTP (Amersham Pharmacia Biotech, Uppsala, Sweden) was added to the PCR reaction mixture. The PCR consisted of 30 cycles: 30 s at 948C, 30 s at 558C, 30 s at 728C, which were initiated by one cycle of 5 min denaturation and ®nished with one 5-min extension step. The PCR products were electrophoresed on 6% polyacrylamide gels with 7 M urea, and the gel was dried and autoradiographed overnight. The genetic distance between the markers are 0 cM in 8 CEPH pedigrees w9x. The dinucleotide-repeat alleles were numbered according to the increasing size on the same gel.
To make certain that the above dinucleotide repeats are informative as a marker in Korean people, allele frequencies of dinucleotide-repeat alleles were determined by typing 57 unrelated and unaffected Korean individuals (ns114). Heterozygosities and polymorphism information content (PIC) values were calculated according to the method of Ott et al. w15x.
Results
Mutation analysis
Five HypoPP patients and their family members from four Korean families were screened for previously known mutations in CACNA1S gene (Arg528His, Arg1239His, and Arg1239Gly). Restriction analysis with BbvI enzyme and sequence analysis showed that three families had Arg528His mutation (Figure 2) , while no such mutation was found in 50 unaffected and unrelated Koreans. Interestingly, we observed de novo Arg528His mutations in two of the three families with Arg528His mutation. Parents of probands in families 1 and 2 were normal according to their medical history and clinical criteria, but their offsprings were affected with hypoPP. As shown in Figure 2 , II-3 of family 1 and II-1 of family 2 displayed the restriction pattern of Arg528His mutation, whereas in I-1 and I-2, the restriction pattern was normal. Restriction analysis with NlaIII enzyme showed that four families did not have the Arg1239His mutation. To detect other mutations surrounding the codons of 528 and 1239 associated with hypoPP, SSCP analysis was performed, but no deleterious mutation was detected.
Haplotype and genetic analysis
To determine how informative each dinucleotide repeat was in the Korean population, we analysed the number of alleles, their size, PIC, and heterozygosity content of the markers in 57 unrelated Korean individuals. The allele frequencies and their standard errors of three markers are summarized in Table 2 . The allele frequency distributions of these markers showed bimodal or more complex aspects. The heterozygosity values for the markers range from 58 to 76%. D1S1723 and CACNL1A3 showed lower heterozygosity values than those found in other studies (Table 3) . But the heterozygosity value for D1S1726 was higher than the value reported for Caucasians. All of these markers were highly informative with PIC values over 0.5. The disease haplotype for each family was determined and is detailed in Figure 3 . All three families have different disease haplotype. Moreover, the haplotype analysis con®rmed de novo Arg528His mutations in two of the families. Interestingly, all the family members in family 3 shared the identical haplotype, which suggests the possibility of consanguinity.
Discussion
Recently, a gene linked to hypoPP has been mapped to chromosome 1q31-32 by linkage analysis in hypoPP families from different European populations. The CACNA1S gene has been mapped to the same region. Mutation analysis has shown that the CACNA1S gene is a major locus for hypoPP. Two point mutations, Arg528His and Arg1239His, are predominant mutations in Caucasian populations w5,9,11x and a Japanese family with Arg528His mutation has been reported w10x. Plassart et al. w16x has also shown the genetic heterogeneity for hypoPP for the ®rst time.
The mutations identi®ed previously (Arg528His and Arg1239His) can be easily detected by PCR ampli®cation and restriction analysis. We performed restriction analysis on four hypoPP families and on 50 unaffected and unrelated Koreans. We detected Arg528His mutations in three families, whereas no such mutation was found in the 50 unaffected and unrelated Koreans. This indicates that the Arg528His mutation caused hypoPP in the Korean population that is of different ethnic background from the Caucasian. Moreover, Arg528His mutations in two of the families (family 1, and 2) were de novo. Two cases of de novo Arg1239His mutation have already been reported w5,11x but a de novo Arg528His mutation has not been reported anywhere.
The choice of genetic markers for human linkage analysis is based on both the location of the marker with respect to a putative disease gene and the degree of polymorphism of the marker. The latter may vary signi®cantly between populations, resulting in a different PIC, which may affect the choice of a particular marker for linkage study. In this study, allele distributions of three markers for hypoPP in the Korean population were bimodal or more complex, and revealed a high degree of polymorphism. Thus, these highly informative polymorphisms will be useful for population-associated and family-based linkage studies in Koreans. The haplotype analysis with the above markers con®rmed the de novo Arg528His mutations in two families.
It is well known from clinical observation that hypoPP can occur sporadically without family history w17x. Concerning the genetic mechanism for these clinical observations, non-penetrances has been reported in families with Arg528His mutation w11,12x and a de novo Arg1239 mutation has been reported w5,11x. Our ®nding of de novo Arg528His mutations provides substantial evidence to support de novo mutation as one of the genetic mechanisms that cause sporadic cases of hypoPP.
No common haplotypes were found in our population of patients with hypoPP. This variety of haplotypes may be due to de novo mutation occurring at two sites (Arg528 and Arg1239). Both 528 and 1239 codons have a CpG dinucleotide and a G to A transition in both sites, resulting in an Arg to His amino acid change. The C to T, or G to A transition in CpG dinucleotides are the most common point mutations within the gene coding regions that cause human genetic diseases w18,19x. In addition to the de novo Arg1239His mutation previously reported, identi®ca-tion of de novo Arg528His mutation in this study shows that the recurrent mutations at 528 and 1239 codons may occur more frequently compared with other mutations that cause genetic diseases. It may be that these two sites are intrinsically unstable, causing point mutation. These recurrent mutations may have also resulted in a variety of haplotypes for hypoPP in many populations. To con®rm the above possibility, extensive genetic studies for hypoPP must be carried out in many populations of different ethnic backgrounds.
